Development of Novel Stand-Alone and Synergistic Agents Relating to Chemo-, Radio- and Immuno-therapy with Reduced Toxicity and Increased Efficacy in Pediatric Gliomas.
Institution:
Kansas Medical Center Research Institute, Inc.Researcher(s):
Patrick GroganGrant Type:
POST Program GrantsYear Awarded:
2011Type of Childhood Cancer:
Brain Tumors